Skip to main content
SpringerLink
Log in

Nahrungsergänzung

  • Chapter
Altersabhängige Makuladegeneration

  • 1259 Accesses

Zusammenfassung

Die altersabhängige Makuladegeneration (AMD) ist in den Industriestaaten die Hauptursache für Erblindung bei Erwachsenen nordeuropäischer Abstammung jenseits des 65. Lebensjahres. Bedingt durch den demographischen Wandel erwartet man in den USA einen dramatischen Prävalenzanstieg der AMD von 1,75 Millionen im Jahr 2000 auf 2,95 Millionen im Jahr 2020 [1]. Angesichts der großen und weiter zunehmenden Krankheitsbelastung für Familien und die Gesellschaft gewinnt die Identifikation beeinflussbarer Risikofaktoren und neuer Möglichkeiten der Präventivbehandlung zunehmend an Wichtigkeit.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Friedman DS, O‘Colmain BJ, Munoz B, et al. (2004) Prevalence of age-related macular degeneration in the United State (2007) Nutritional supplementation in age-related macular degeneration. Curr Opin Ophthalmol 18(3):220–223

    Google Scholar 

  2. Coleman H, Chew E (2007) Nutritional supplementation in age-related macular degeneration. Curr Opin Ophthalmol 18(3):220–223

    Article  PubMed  Google Scholar 

  3. Evans JR (2006) Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev (2):CD000254

    Google Scholar 

  4. Evans JR, Henshaw K (2000) Antioxidant vitamin and mineral supplementation for preventing age-related macular degeneration. Cochrane Database Syst Rev (2):CD000253

    Google Scholar 

  5. Evans JR, Henshaw K (2008) Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database Syst Rev (1):CD000253

    Google Scholar 

  6. Johnson EJ (2010) Age-related macular degeneration and antioxidant vitamins: recent findings. Curr Opin Clin Nutr Metab Care 13(1):28–33

    Article  PubMed  Google Scholar 

  7. Ding X, Patel M, Chan CC (2009) Molecular pathology of agerelated macular degeneration. Prog Retin Eye Res 28(1):1–18

    Article  PubMed  CAS  Google Scholar 

  8. Ferris FL, Davis MD, Clemons TE, et al. (2005) A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol 123(11):1570–1574

    Article  PubMed  Google Scholar 

  9. Bressler NM, Bressler SB, Congdon NG, et al. (2003) Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol 121(11):1621–1624

    Article  PubMed  Google Scholar 

  10. Borger PH, van Leeuwen R, Hulsman CA, et al. (2003) Is there a direct association between age-related eye diseases and mortality? The Rotterdam Study. Ophthalmology 110(7):1292–1296

    Article  PubMed  Google Scholar 

  11. Clemons TE, Kurinij N, Sperduto RD (2004) Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. Arch Ophthalmol 122(5):716–726

    Article  PubMed  CAS  Google Scholar 

  12. Chew EY, Clemons T (2005) Vitamin E and the age-related eye disease study supplementation for age-related macular degeneration. Arch Ophthalmol 123(3):395–396

    Article  PubMed  Google Scholar 

  13. Nebeling LC, Forman MR, Graubard BI, Snyder RA (1997) Changes in carotenoid intake in the United States: the 1987 and 1992 National Health Interview Surveys. J Am Diet Assoc 97(9):991–996

    Article  PubMed  CAS  Google Scholar 

  14. Nebeling LC, Forman MR, Graubard BI, Snyder RA (1997) The impact of lifestyle characteristics on carotenoid intake in the United States: the 1987 National Health Interview Survey. Am J Public Health 87(2):268–271

    Article  PubMed  CAS  Google Scholar 

  15. Sommerburg O, Keunen JE, Bird AC, van Kuijk FJ (1998) Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol 82(8):907–910

    Article  PubMed  CAS  Google Scholar 

  16. AREDS (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119(10):1417–1436

    Google Scholar 

  17. Teikari JM, Laatikainen L, Virtamo J, et al. (1998) Six-year supplementation with alpha-tocopherol and beta-carotene and agerelated maculopathy. Acta Ophthalmol Scand 76(2):224–229

    Article  PubMed  CAS  Google Scholar 

  18. Tan JS, Wang JJ, Flood V, Rochtchina E, Smith W, Mitchell P (2008) Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 115(2):334–341

    Article  PubMed  Google Scholar 

  19. van Leeuwen R, Boekhoorn S, Vingerling JR, et al. (2005) Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 294(24):3101–3107

    Article  PubMed  Google Scholar 

  20. Chiu CJ, Milton RC, Klein R, Gensler G, Taylor A (2009) Dietary compound score and risk of age-related macular degeneration in the age-related eye disease study. Ophthalmology 116(5):939–946

    Article  PubMed  Google Scholar 

  21. Christen WG, Manson JE, Glynn RJ, et al. (2007) Beta carotene supplementation and age-related maculopathy in a randomized trial of US physicians. Arch Ophthalmol 125(3):333–339

    Article  PubMed  CAS  Google Scholar 

  22. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers.. N Engl J Med 330(15):1029–1035

    Article  Google Scholar 

  23. Omenn GS, Goodman GE, Thornquist MD, et al. (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334(18):1150–1155

    Article  PubMed  CAS  Google Scholar 

  24. Hennekens CH, Buring JE, Manson JE, et al. (1996) Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334(18):1145–1149

    Article  PubMed  CAS  Google Scholar 

  25. AREDS2 Manual of Procedures www.areds2.org

  26. Loane E, Kelliher C, Beatty S, Nolan JM (2008) The rationale and evidence base for a protective role of macular pigment in agerelated maculopathy. Br J Ophthalmol 92(9):1163–1168

    Article  PubMed  CAS  Google Scholar 

  27. Snodderly DM, Auran JD, Delori FC (1984) The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci 25(6):674–685

    CAS  Google Scholar 

  28. Snodderly DM, Brown PK, Delori FC, Auran JD (1984) The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 25(6):660–673

    PubMed  CAS  Google Scholar 

  29. Nolan JM, Stack J, O OD, Loane E, Beatty S (2007) Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Exp Eye Res 84(1):61–74

    Article  PubMed  CAS  Google Scholar 

  30. Trieschmann M, Beatty S, Nolan JM, et al. (2007) Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res 84(4):718–728

    Article  PubMed  CAS  Google Scholar 

  31. Schalch W, Cohn W, Barker FM, et al. (2007) Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin – the LUXEA (LUtein Xanthophyll Eye Accumulation) study. Arch Biochem Biophys 458(2):128–135

    Article  PubMed  CAS  Google Scholar 

  32. Rosenthal JM, Kim J, de Monasterio F, et al. (2006) Dose-ranging study of lutein supplementation in persons aged 60 years or older. Invest Ophthalmol Vis Sci 47(12):5227–5233

    Article  PubMed  Google Scholar 

  33. SanGiovanni JP, Chew EY, Clemons TE, et al. 2007 () The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol 125(9):1225–1232

    Article  PubMed  CAS  Google Scholar 

  34. Tan JS, Wang JJ, Flood V, Mitchell P (2009) Dietary fatty acids and the 10-year incidence of age-related macular degeneration: the Blue Mountains Eye Study. Arch Ophthalmol 127(5):656–665

    Article  PubMed  CAS  Google Scholar 

  35. Cho E, Hankinson SE, Rosner B, Willett WC, Colditz GA (2008) Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration. Am J Clin Nutr 87(6):1837–1843

    PubMed  CAS  Google Scholar 

  36. Moeller SM, Parekh N, Tinker L, et al. (2006) Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women‘s Health Initiative. Arch Ophthalmol 124(8):1151–1162

    Article  PubMed  CAS  Google Scholar 

  37. Delcourt C, Carriere I, Delage M, Barberger-Gateau P, Schalch W (2006) Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study. Invest Ophthalmol Vis Sci 47(6):2329–2335

    Article  PubMed  Google Scholar 

  38. Seddon JM, Ajani UA, Sperduto RD, et al. (1994) Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 272(18):1413–1420

    Article  PubMed  CAS  Google Scholar 

  39. Trumbo PR, Ellwood KC (2006) Lutein and zeaxanthin intakes and risk of age-related macular degeneration and cataracts: an evaluation using the Food and Drug Administration‘s evidence-based review system for health claims. Am J Clin Nutr 84(5):971–974

    PubMed  CAS  Google Scholar 

  40. SanGiovanni JP, Chew EY( 2005) The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 24(1):87–138

    Article  PubMed  CAS  Google Scholar 

  41. Bannenberg G, Arita M, Serhan CN (2007) Endogenous receptor agonists: resolving inflammation. Scientific World J 7:1440–1462

    CAS  Google Scholar 

  42. Bazan NG (2006) Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends Neurosci 29(5):263–271

    Article  PubMed  CAS  Google Scholar 

  43. Bazan NG (2008) Neurotrophins induce neuroprotective signaling in the retinal pigment epithelial cell by activating the synthesis of the anti-inflammatory and anti–apoptotic neuroprotectin D1. Adv Exp Med Bio 613:39–44

    Article  CAS  Google Scholar 

  44. Serhan CN (2009) Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators. J Thromb Haemost 7 Suppl 1:44–48

    Article  PubMed  CAS  Google Scholar 

  45. Serhan CN, Chiang N, Van Dyke TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8(5):349–361

    Article  PubMed  CAS  Google Scholar 

  46. Weylandt KH, Kang JX (2005) Rethinking lipid mediators. Lancet 366(9486):618–620

    Article  PubMed  Google Scholar 

  47. Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG (2004) Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA 101(22):8491–8496

    Article  PubMed  CAS  Google Scholar 

  48. Sangiovanni JP, Agron E, Meleth AD, et al. (2009) {omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study. Am J Clin Nutr 90(6):1601–1607

    Article  PubMed  CAS  Google Scholar 

  49. Augood C, Chakravarthy U, Young I, et al. (2008) Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am J Clin Nutr 88(2):398–406

    PubMed  CAS  Google Scholar 

  50. Chong EW, Kreis AJ, Wong TY, Simpson JA, Guymer RH (2008) Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol 126(6):826–833

    Article  PubMed  Google Scholar 

  51. Seddon JM, George S, Rosner B (2006) Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol 124(7):995–1001

    Article  PubMed  CAS  Google Scholar 

  52. Huang LL, Coleman HR, Kim J, et al. (2008) Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMD. Invest Ophthalmol Vis Sci 49(9):3864–3869

    Article  PubMed  Google Scholar 

  53. Chiu CJ, Klein R, Milton RC, Gensler G, Taylor A (2009) Does eating particular diets alter the risk of age-related macular degeneration in users of the Age-Related Eye Disease Study supplements? Br J Ophthalmol 93(9):1241–1246

    Article  PubMed  Google Scholar 

  54. SanGiovanni JP, Agron E, Clemons TE, Chew EY (2009) Omega-3 long-chain polyunsaturated fatty acid intake inversely associated with 12-year progression to advanced age-related macular degeneration. Arch Ophthalmol 127(1):110–112

    Article  PubMed  Google Scholar 

  55. SanGiovanni JP, Chew EY, Clemons TE, et al. (2007) The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol 125(5):671–679

    Article  PubMed  CAS  Google Scholar 

  56. Chong EW, Robman LD, Simpson JA, et al. (2009) Fat consumption and its association with age-related macular degeneration. Arch Ophthalmol 127(5):674–680

    Article  PubMed  CAS  Google Scholar 

  57. Heuberger RA, Mares-Perlman JA, Klein R, Klein BE, Millen AE, Palta M (2001) Relationship of dietary fat to age-related maculopathy in the Third National Health and Nutrition Examination Survey. Arch Ophthalmol 119(12):1833–1838

    PubMed  CAS  Google Scholar 

  58. Katz ML, Robison WG, Jr. (1987) Light and aging effects on vitamin E in the retina and retinal pigment epithelium. Vision Res 27(11):1875–1879

    Article  PubMed  CAS  Google Scholar 

  59. Supplements OoD. Vitamin E. http://dietary-supplements.info.nih.gov/factsheets/[60] Taylor HR, Tikellis G, Robman LD, McCarty CA, McNeil JJ (2002) Vitamin E supplementation and macular degeneration: randomised controlled trial. BMJ 325(7354):11

    Google Scholar 

  60. Christen WG, Ajani UA, Glynn RJ, et al. (1999) Prospective cohort study of antioxidant vitamin supplement use and the risk of agerelated maculopathy. Am J Epidemiol 149(5):476–484

    PubMed  CAS  Google Scholar 

  61. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and metaanalysis. JAMA 297(8):842–857

    Article  PubMed  CAS  Google Scholar 

  62. Hosoya K, Nakamura G, Akanuma S, Tomi M, Tachikawa M (2008) Dehydroascorbic acid uptake and intracellular ascorbic acid accumulation in cultured Muller glial cells (TR-MUL). Neurochem Int 52(7):1351–1357

    Article  PubMed  CAS  Google Scholar 

  63. Supplements OoD. Vitamin C. http://dietary-supplements.info.nih.gov/factsheets/

  64. Friedman PA, Zeidel ML (1999) Victory at C. Nat Med 5(6):620–621

    Article  PubMed  CAS  Google Scholar 

  65. Stoyanovsky DA, Goldman R, Darrow RM, Organisciak DT, Kagan VE (1995) Endogenous ascorbate regenerates vitamin E in the retina directly and in combination with exogenous dihydrolipoic acid. Curr Eye Res 14(3):181–189

    Article  PubMed  CAS  Google Scholar 

  66. Grahn BH, Paterson PG, Gottschall-Pass KT, Zhang Z (2001) Zinc and the eye. J Am Coll Nutr 20(2 Suppl):106–118

    PubMed  CAS  Google Scholar 

  67. Supplements OoD. Zinc. http://dietary-supplements.info.nih.gov/factsheets/

  68. Wills NK, Ramanujam VM, Kalariya N, Lewis JR, van Kuijk FJ (2008) Copper and zinc distribution in the human retina: relationship to cadmium accumulation, age, and gender. Exp Eye Res 87(2):80–88

    Article  PubMed  CAS  Google Scholar 

  69. Karcioglu ZA (1982) Zinc in the eye. Surv Ophthalmol 27(2):114–122

    Article  PubMed  CAS  Google Scholar 

  70. Cunningham-Rundles S, Cunningham-Rundles C, Dupont B, Good RA (1980) Zinc-induced activation of human B lymphocytes. Clin Immunol Immunopathol 16(1):115–122

    Article  PubMed  CAS  Google Scholar 

  71. Hurley LS, Swenerton H (1966) Congenital malformations resulting from zinc deficiency in rats. Proc Soc Exp Biol Med 123(3):692–696

    PubMed  CAS  Google Scholar 

  72. Morrison SA, Russell RM, Carney EA, Oaks EV (1978) Zinc deficiency: a cause of abnormal dark adaptation in cirrhotics. Am J Clin Nutr 31(2):276–281

    PubMed  CAS  Google Scholar 

  73. Prasad AS (1991) Discovery of human zinc deficiency and studies in an experimental human model. Am J Clin Nutr 53(2):403–412

    PubMed  CAS  Google Scholar 

  74. Tate DJ, Miceli MV, Newsome DA, Alcock NW, Oliver PD (1995) Influence of zinc on selected cellular functions of cultured human retinal pigment epithelium. Curr Eye Res 14(10):897–903

    Article  PubMed  CAS  Google Scholar 

  75. Olin KL, Golub MS, Gershwin ME, Hendrickx AG, Lonnerdal B, Keen CL (1995) Extracellular superoxide dismutase activity is affected by dietary zinc intake in nonhuman primate and rodent models. Am J Clin Nutr 61(6):1263–1267

    PubMed  CAS  Google Scholar 

  76. Newsome DA, Swartz M, Leone NC, Elston RC, Miller E (1988) Oral zinc in macular degeneration. Arch Ophthalmol 106(2):192–198

    PubMed  CAS  Google Scholar 

  77. Newsome DA (2008) A randomized, prospective, placebo-controlled clinical trial of a novel zinc-monocysteine compound in age-related macular degeneration. Curr Eye Res 33(7):591–598

    Article  PubMed  CAS  Google Scholar 

  78. VandenLangenberg GM, Mares-Perlman JA, Klein R, Klein BE, Brady WE, Palta M (1998) Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol 148(2):204–214

    PubMed  CAS  Google Scholar 

  79. Stur M, Tittl M, Reitner A, Meisinger V (1996) Oral zinc and the second eye in age-related macular degeneration. Invest Ophthalmol Vis Sci 37(7):1225–1235

    PubMed  CAS  Google Scholar 

  80. AREDS (2002) The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS Report No. 7. J Nutr 132(4):697–702

    Google Scholar 

  81. Klein ML, Francis PJ, Rosner B, et al. (2008) CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology 115(6):1019–1025

    Article  PubMed  Google Scholar 

  82. Supplements OoD. Folate/B12. http://dietary-supplements.info.nih.gov/factsheets/

  83. Axer-Siegel R, Bourla D, Ehrlich R, et al. (2004) Association of neovascular age-related macular degeneration and hyperhomocysteinemia. Am J Ophthalmol 137(1):84–89

    Article  PubMed  Google Scholar 

  84. Heuberger RA, Fisher AI, Jacques PF, et al. (2002) Relation of blood homocysteine and its nutritional determinants to agerelated maculopathy in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 76(4):897–902

    PubMed  CAS  Google Scholar 

  85. Nowak M, Swietochowska E, Wielkoszynski T, et al. (2005) Homocysteine, vitamin B12, and folic acid in age-related macular degeneration. Eur J Ophthalmol 15(6):764–767

    PubMed  CAS  Google Scholar 

  86. Rochtchina E, Wang JJ, Flood VM, Mitchell P (2007) Elevated serum homocysteine, low serum vitamin B12, folate, and agerelated macular degeneration: the Blue Mountains Eye Study. Am J Ophthalmol 143(2):344–346

    Article  PubMed  CAS  Google Scholar 

  87. Woo KS, Chook P, Lolin YI, Sanderson JE, Metreweli C, Celermajer DS (1999) Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. J Am Coll Cardiol 34(7):2002–2006

    Article  PubMed  CAS  Google Scholar 

  88. Moore P, El-sherbeny A, Roon P, Schoenlein PV, Ganapathy V, Smith SB (2001) Apoptotic cell death in the mouse retinal ganglion cell layer is induced in vivo by the excitatory amino acid homocysteine. Exp Eye Res 73(1):45–57

    Article  PubMed  CAS  Google Scholar 

  89. van Leeuwen R, Ikram MK, Vingerling JR, Witteman JC, Hofman A, de Jong PT (2003) Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 44(9):3771–3777

    Article  PubMed  Google Scholar 

  90. Ramrattan RS, Van Der Schaft TL, Mooy CM, de Bruijn WC, Mulder PG, de Jong PT (1994) Morphometric analysis of Bruch‘s membrane, the choriocapillaris, and the choroid in aging. Invest Ophthalmol Vis Sci 35(6):2857–2864

    PubMed  CAS  Google Scholar 

  91. Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, de Jong PT (1995) Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 142(4):404–409

    PubMed  CAS  Google Scholar 

  92. Christen WG, Glynn RJ, Chew EY, Albert CM, Manson JE (2009) Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women‘s Antioxidant and Folic Acid Cardiovascular Study. Arch Intern Med 169(4):335–341

    Article  PubMed  CAS  Google Scholar 

  93. Hayden MR, Tyagi SC (2004) Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation. Nutr J 3:4

    Article  PubMed  Google Scholar 

  94. Homocysteine Lowering Trialists’ Collaboration (2005) Dosedependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 82(4):806–812

    Google Scholar 

  95. Doshi SN, McDowell IF, Moat SJ, et al. (2002) Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 105(1):22–26

    Article  PubMed  CAS  Google Scholar 

  96. Moat SJ, Lang D, McDowell IF, et al. (2004) Folate, homocysteine, endothelial function and cardiovascular disease. J Nutr Biochem 15(2):64–79

    Article  PubMed  CAS  Google Scholar 

  97. Verhaar MC, Wever RM, Kastelein JJ, van Dam T, Koomans HA, Rabelink TJ (1998) 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation 97(3):237–241

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Eye Institute, National Institutes of Health, (301)496-6583, Bethesda, MD, USA

    Dr. A. D. Meleth, Dr. Nupura Krishnadev & Prof. Dr. Emily Y. Chew

  2. Department of Ophthalmology, George Washington University, (202)741-2825, Washington, DC, USA

    Dr. Veena R. Raiji

Authors
  1. Dr. A. D. Meleth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. Veena R. Raiji
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dr. Nupura Krishnadev
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Prof. Dr. Emily Y. Chew
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Meleth, A., Raiji, V., Krishnadev, N., Chew, E. (2011). Nahrungsergänzung. In: Altersabhängige Makuladegeneration. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-20870-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-20870-6_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-20869-0

  • Online ISBN: 978-3-642-20870-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation